愛爾眼科(300015.SZ)擬收購26家醫院部分股權及眾生藥業旗下德視光學100%股權與宣城眼科80%股權 明起停牌
格隆匯10月22日丨愛爾眼科(300015.SZ)公佈,公司正在籌劃以發行股份及支付現金方式購買資產並募集配套資金事項,並向深圳證券交易所申請了公司股票自2019年10月23日上午開市起停牌,為了保證公平信息披露,維護廣大投資者的利益。
公司擬以發行股份方式購買磐信(上海)投資中心(有限合夥)、磐茂(上海)投資中心(有限合夥)合計持有的天津中視信企業管理有限公司100%股權,擬以發行股份及支付現金方式購買廣東眾生藥業股份有限公司持有的湛江奧理德視光學中心有限公司100%股權與宣城市眼科醫院有限公司80%股權,並募集配套資金。此次交易預計不構成重大資產重組,預計不構成關聯交易。
天津中視信企業管理有限公司經營範圍:企業管理服務;企業管理諮詢。(依法須經批准的項目,經相關部門批准後方可開展經營活動)。
天津中視信企業管理有限公司是為此次交易設立的公司。天津中視信企業管理有限公司擬從湖南愛爾中鈺眼科醫療產業投資合夥企業(有限合夥)、南京愛爾安星眼科醫療產業投資中心(有限合夥)、湖南亮視交銀眼科醫療合夥企業(有限合夥)收購26家醫院的部分股權。
湛江奧理德視光學中心有限公司經營範圍:銷售:眼鏡及配件;驗光配鏡,零售:醫療器械,保健食品。
宣城市眼科醫院有限公司經營範圍:眼科/醫學檢驗科;臨牀體液、血液專業;臨牀微生物學專業;臨牀化學檢驗專業;臨牀免疫、血清學專業;驗光配鏡;房屋租賃;軟、硬性角膜接觸鏡驗配、銷售及護理產品銷售;預包裝食品(不含冷凍冷藏食品)銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.